Phase II/III Study of Radiofrequency Ablation Combined with Cytokine-Induced Killer Cells Treating Colorectal Liver Metastases | Zendy

Xiao-Dong Li | Zendy; Xichao Dai | Zendy; Liangrong Shi | Zendy; Yong Jiang | Zendy; Xuemin Chen | Zendy; Lujun Chen | Zendy; Jiemin Zhao | Zendy; Weiguang Qiang | Zendy; Jun Wu | Zendy; Mei Ji | Zendy; Jingting Jiang | Zendy; Changping Wu | Zendy

Open Access

Phase II/III Study of Radiofrequency Ablation Combined with Cytokine-Induced Killer Cells Treating Colorectal Liver Metastases

Author(s) -

Xiao-Dong Li,

Xichao Dai,

Liangrong Shi,

Yong Jiang,

Xuemin Chen,

Lujun Chen,

Jiemin Zhao,

Weiguang Qiang,

Jun Wu,

Mei Ji,

Jingting Jiang,

Changping Wu

Publication year - 2016

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000452531

Subject(s) - medicine , radiofrequency ablation , cytokine induced killer cell , gastroenterology , group b , group a , cytokine , urology , ablation , immunology , immune system , cd3 , cd8

This phase II/III, non-randomized clinical trial aimed to determine the efficacy and safety of the combination of radiofrequency ablation (RFA) and cytokine-induced killer (CIK) cells transfusion for patients with colorectal liver metastases (CRLMs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research